The purpose of this study is to collect CSF and blood samples that can be used in future research studies to identify potential biomarkers in blood and cerebrospinal fluid (CSF) collected in Amyotrophic Lateral Sclerosis (ALS) patients.
Biomarkers are non-genetic elements in your blood and CSF that may help diagnose and monitor ALS more easily. There are no readily available sources of longitudinal CSF, plasma or serum samples from people with ALS, ALS-FTD or similar neurodegenerative disorders or their family members for use in the identification of potential ALS biomarkers. Future research will examine potential biomarkers in blood and CSF collected over time to see if they change over time and can be used to diagnose and monitor people with ALS.
Study Type
OBSERVATIONAL
Enrollment
100
Mayo Clinic in Florida
Jacksonville, Florida, United States
RECRUITINGBlood serum collection
Total number of blood serum samples collected
Time frame: 10 years
Blood plasma collection
Total number of blood plasma samples collected
Time frame: 10 years
Cerebrospinal fluid collection
Total number of cerebrospinal fluid samples collected
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.